|
The explant did not return for evaluation.Radiographs were provided which confirm the event of a collapsed cage at the inferior level.The lot number was not provided; therefore, a review of device history records cannot be performed.Based on the information provided, the root cause cannot be determined.Alphatec spine is submitting this report in compliance with fda regulations under 21 cfr 803.All relevant and available information has been included to the best of our knowledge at the time of this submission.Any fields left blank reflect information that was not known or not provided.Should additional details become available, a supplemental report will be submitted accordingly.Warnings/cautions: potential risks identified with the use of these fusion devices, which may require additional surgery, include device component failure, loss of fixation, pseudarthrosis (i.E., non-union), fracture of the vertebra, neurological injury, and/or vascular or visceral injury.Possible adverse effects: initial or delayed loosening, bending, dislocation, and/or breakage of device components.Postoperative management: the surgeon should instruct the patient regarding the amount and time frame after surgery of any weight bearing activity.The increased risk of bending, dislocation, and/or breakage of the implanted devices, as well as an undesired surgical result are consequences of any type of early or excessive weight bearing, vibratory motion, falls, jolts or other movements preventing proper healing and/or fusion development.Immobilization should be considered in order to prevent bending, dislocation, or breakage of the implanted device in case of delayed, malunion, or nonunion of bone.Immobilization should continue until a complete bone fusion mass has developed and been confirmed.
|